EP Patent

EP3893877A1 — Compositions, devices, and methods for treating or preventing headaches

Assigned to Satsuma Pharmaceuticals Inc · Expires 2021-10-20 · 5y expired

What this patent protects

Disclosed herein are pharmaceutical compositions, devices, their combinations, and their uses thereof for example in treating or preventing headaches. The present disclosure provides new methods of medical treatment or prevention (e.g, for headaches) resulting in unexpected super…

USPTO Abstract

Disclosed herein are pharmaceutical compositions, devices, their combinations, and their uses thereof for example in treating or preventing headaches. The present disclosure provides new methods of medical treatment or prevention (e.g, for headaches) resulting in unexpected superior pharmacokinetics compared to conventional methods. In some instances, the methods herein can produce a unique pharmacokinetic profile of a metabolite.

Drugs covered by this patent

Patent Metadata

Patent number
EP3893877A1
Jurisdiction
EP
Classification
—
Expires
2021-10-20
Drug substance claim
No
Drug product claim
No
Assignee
Satsuma Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.